Alexander Kenigsberg, MD, discusses a new nonsurgical, robotic-focused ultrasound procedure for prostate cancer.

The new program at Hampton University’s Proton Cancer Institute works like a registry where patients undergoing treatment can ...

The global glioblastoma treatment drugs market is on the cusp of transformative growth. With market revenues expected to surge from approximately USD 844.8 million in 2025 to a projected USD 1,470.5 ...

AP Biosciences, a clinical-stage biopharmaceutical company dedicated to transforming cancer therapy through development of innovative bispecific antibodies, today announced that it has dosed the first ...

Gilead Sciences said on Monday a late-stage study showed that its drug Trodelvy used in combination with Merck's ...

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

Genetic testing plays a crucial role in identifying potential risks early and guiding reproductive decisions. One important ...

Oncotelic Therapeutics, Inc. (OTCQB:OTLC), a biotechnology company focused on nanomedicine and RNA-based therapeutics, announced today that its Chairman and CEO, Dr. Vuong Trieu, will deliver a ...

Short term trials with surrogate measures instead of hard outcomes are often used to study chronic diseases. The effects of an intervention may, however, take time to develop and persist after ...

The Invasive Fungal Infection (IFI) market is witnessing a transformative shift driven by innovative solutions aimed at combating these pervasive threats to human health. With a growing incidence of ...

Q1 2025 Earnings Conference Call April 22, 2025 8:00 AM ETCompany ParticipantsJohn Bedford - VP, IRRainer Blair - ...